Your browser doesn't support javascript.
loading
BET bromodomain inhibition as a therapeutic strategy to target c-Myc.
Delmore, Jake E; Issa, Ghayas C; Lemieux, Madeleine E; Rahl, Peter B; Shi, Junwei; Jacobs, Hannah M; Kastritis, Efstathios; Gilpatrick, Timothy; Paranal, Ronald M; Qi, Jun; Chesi, Marta; Schinzel, Anna C; McKeown, Michael R; Heffernan, Timothy P; Vakoc, Christopher R; Bergsagel, P Leif; Ghobrial, Irene M; Richardson, Paul G; Young, Richard A; Hahn, William C; Anderson, Kenneth C; Kung, Andrew L; Bradner, James E; Mitsiades, Constantine S.
Affiliation
  • Delmore JE; Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
Cell ; 146(6): 904-17, 2011 Sep 16.
Article in En | MEDLINE | ID: mdl-21889194
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proto-Oncogene Proteins c-myc / Drug Discovery / Multiple Myeloma / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2011 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Proto-Oncogene Proteins c-myc / Drug Discovery / Multiple Myeloma / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Year: 2011 Type: Article